Let’s Have a Little Chat About the HPV Vaccine
Gardasil 9 is the only HPV vaccine used in the U.S., and it’s also one of the only vaccines on the market that actually ...
The HPV vaccine could eliminate 6 types of cancer. Why don’t more people get it?
The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are strains 6, 11 ...
It took me 10 years to get the HPV vaccine. Let's talk about the facts. | Opinion
My medical degree and conversations with doctors helped me understand why it makes sense for adolescents to be vaccinated, ...
ABC11 on MSN11d
Drugmaker Merck opens state-of-art $1B facility to manufacture HPV Gardasil, other vaccines
Drugmaker Merck announced Tuesday the opening of a new facility in North Durham. The $1 billion plant will manufacture the HPV vaccines Gardasil and Gardasil 9, while the site continues to produce ...
Gardasil maker completes $1B North Carolina expansion — more growth on the way
New facility will manufacture HPV vaccines Gardasil and Gardasil 9. Merck plans to invest $8 billion more in U.S. by 2028. A ...
Merck opens $1 billion addition in north Durham to boost production of popular vaccine
The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...
SHINE4d
MSD eyes new public health approaches after HPV vaccine's expanded approval
Biopharma giant MSD says it stands ready to pursue new approaches to advance public health in China after its GARDASIL ...
Reuters12d
Merck prevails in US safety litigation over Gardasil HPV vaccine
Gardasil and Gardasil 9 are together Merck's second best-selling ... federal data show. The vaccine was first approved in the U.S. in 2006. U.S. Health and Human Services Secretary Robert F.
Federal judge rules in favor of drugmaker in HPV vaccine case
CHARLOTTE — A federal judge granted summary judgment in favor of Merck for part of the litigation involving the HPV vaccine, ...
Merck Injects $1 Billion To Expand Vaccine Production In US
Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and ...